XtalPi
About XtalPi
XtalPi
XtalPi is an AI-driven drug discovery company leveraging quantum physics algorithms, artificial intelligence, and robotics to accelerate pharmaceutical research. Founded by three MIT quantum physicists, the company uses quantum calculations for molecular structures to train proprietary AI large language models that screen billions of molecules for drug candidates, increasing chemical experiment success rates from 20-30% to 90%. XtalPi serves nearly 80% of global big pharma including Pfizer, Eli Lilly, Johnson & Johnson, and Merck, with a $6 billion collaboration with DoveTree Medicines announced in 2025.
Company Information
- Founded: 2014
- Country: China
- Website: https://en.xtalpi.com
- Categories: quantum software, quantum pharma
Related Companies
Explore other quantum computing companies in similar categories or regions.
Company Information
⚠️ Important Disclaimer
Information for Educational Purposes Only: All information about XtalPi is provided for informational and educational purposes only. This is not investment, financial, or professional advice.
No Warranties: While we strive for accuracy, Quantum Zeitgeist makes no warranties regarding the accuracy, completeness, or timeliness of company information. The quantum technology industry evolves rapidly, and information may become outdated.
No Endorsement: Inclusion in Quantum Navigator does not constitute an endorsement, recommendation, or verification of XtalPi's claims, technology, or business viability.
Do Your Own Research: Always conduct independent due diligence and consult qualified professionals (financial advisors, lawyers, etc.) before making investment, business, or career decisions.
For more information, see our Terms of Service and Privacy Policy.